Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

UTHR

United Therapeutics Corp

Jul 26 • 04:00PM ET

338.22

Dollar change +1.85
Percentage change 0.55	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IJH VTI VB VBR XBI VXF COWZ MDY IBB SPMD

Scroll to Statements

Index	-	P/E	15.99	EPS (ttm)	21.15	Insider Own	1.75%	Shs Outstand	47.04M	Perf Week	2.75%
Market Cap	15.01B	Forward P/E	11.93	EPS next Y	28.36	Insider Trans	-47.74%	Shs Float	43.59M	Perf Month	6.04%
Income	1.05B	PEG	1.65	EPS next Q	6.50	Inst Own	103.68%	Short Float	9.57%	Perf Quarter	43.34%
Sales	2.50B	P/S	6.01	EPS this Y	30.11%	Inst Trans	1.03%	Short Ratio	7.39	Perf Half Y	54.21%
Book/sh	120.76	P/B	2.80	EPS next Y	10.03%	ROA	16.36%	Short Interest	4.17M	Perf Year	39.28%
Cash/sh	61.03	P/C	5.54	EPS next 5Y	9.70%	ROE	20.08%	52W Range	208.62 - 343.98	Perf YTD	53.81%
Dividend Est.	-	P/FCF	19.87	EPS past 5Y	8.15%	ROI	18.97%	52W High	-1.67%	Beta	0.55
Dividend TTM	-	Quick Ratio	3.64	Sales past 5Y	8.02%	Gross Margin	88.87%	52W Low	62.12%	ATR (14)	7.28
Dividend Ex-Date	-	Current Ratio	3.77	EPS Y/Y TTM	40.71%	Oper. Margin	50.31%	RSI (14)	70.76	Volatility	2.10% 2.22%
Employees	1168	Debt/Eq	0.11	Sales Y/Y TTM	26.09%	Profit Margin	42.05%	Recom	1.87	Target Price	332.73
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	27.02%	Payout	0.00%	Rel Volume	0.51	Prev Close	336.37
Sales Surprise	9.25%	EPS Surprise	8.13%	Sales Q/Q	33.70%	Earnings	Jul 31 BMO	Avg Volume	564.58K	Price	338.22
SMA20	4.18%	SMA50	12.65%	SMA200	36.13%	Trades		Volume	290,257	Change	0.55%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-11-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$310 → $321
Feb-12-24	Upgrade	Goldman	Sell → Neutral	$213 → $215
Feb-05-24	Initiated	Leerink Partners	Outperform	$330
Dec-08-23	Initiated	Wells Fargo	Overweight	$309
Dec-06-22	Initiated	UBS	Buy	$320
Dec-05-22	Initiated	Goldman	Sell	$230
Oct-11-22	Initiated	Morgan Stanley	Overweight	$288
Sep-20-22	Reiterated	BofA Securities	Underperform
Sep-19-22	Resumed	Wedbush	Outperform	$263
Feb-11-22	Initiated	BTIG Research	Neutral
Jul-14-21	Upgrade	Argus	Hold → Buy	$205
Apr-26-21	Resumed	Credit Suisse	Outperform	$196
Feb-01-21	Upgrade	H.C. Wainwright	Neutral → Buy	$125 → $195
Sep-14-20	Resumed	JP Morgan	Overweight	$142
Jun-25-20	Reiterated	H.C. Wainwright	Neutral	$85 → $125
Mar-10-20	Upgrade	Jefferies	Hold → Buy	$123
Feb-27-20	Upgrade	Cowen	Market Perform → Outperform	$119 → $145
Jan-31-20	Upgrade	JP Morgan	Neutral → Overweight	$120
Dec-03-19	Initiated	BofA/Merrill	Underperform
Aug-01-19	Upgrade	Ladenburg Thalmann	Neutral → Buy	$103 → $106

Show Previous Ratings

Today 09:49AM	Implied Volatility Surging for United Therapeutics (UTHR) Stock Options (Zacks)
Jul-24-24 07:00AM	United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024 (Business Wire)
Jul-20-24 11:42AM	Meet some of the world's cleanest pigs, raised to grow kidneys and hearts for humans (Associated Press Finance)
Jul-17-24 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
Jul-15-24 09:04PM	3 Biotech Stocks to Buy Now: Q3 Edition (InvestorPlace)
12:45PM	Loading…
12:45PM	Is United Therapeutics (UTHR) a Solid Growth Stock? 3 Reasons to Think 'Yes' (Zacks)
12:00PM	What Makes United Therapeutics (UTHR) a Strong Momentum Stock: Buy Now? (Zacks)
09:15AM	United Therapeutics Corporation (UTHR) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jul-12-24 09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Jul-11-24 09:50AM	Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term (Zacks)
09:02AM	United Therapeutics (UTHR) Completes Enrolment in IPF Study (Zacks)
04:52AM	United Therapeutics TETON 2 study achieves full enrolment for IPF treatment (Clinical Trials Arena)
Jul-10-24 07:00AM	United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis (Business Wire)
Jul-09-24 12:10PM	Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-08-24 11:23AM	3 Undervalued Stocks on Track to Double (or More) by 2028 (InvestorPlace)
02:18PM	Loading…
Jul-01-24 02:18PM	7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
Jun-28-24 10:36AM	Big Money Elevating United Therapeutics (FX Empire)
Jun-27-24 07:00AM	United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors (Business Wire)
Jun-26-24 03:02PM	Why United Therapeutics, An IBD 50 Stock, Has Surged 36% Over Nine Weeks (Investor's Business Daily)
09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
Jun-21-24 03:10AM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-20-24 03:58PM	The 3 Best Medical Device Stocks to Buy in June 2024 (InvestorPlace)
Jun-18-24 07:00PM	Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-14-24 07:00PM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-07-24 09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Jun-05-24 07:00AM	United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
Jun-04-24 02:18PM	The 3 Most Undervalued Healthcare Stocks to Buy in June 2024 (InvestorPlace)
Jun-03-24 04:33PM	Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics (Investor's Business Daily)
May-31-24 11:31AM	Why Is United Therapeutics (UTHR) Up 4.8% Since Last Earnings Report? (Zacks)
May-30-24 09:50AM	Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock (Zacks)
10:11AM	Loading…
May-27-24 10:11AM	3 Underappreciated Biotech Stocks to Buy Now: May 2024 (InvestorPlace)
May-23-24 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
May-22-24 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
04:56AM	Latest 340B ruling delivers blow to providers (Healthcare Dive)
May-20-24 01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
May-16-24 07:01PM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
07:01PM	Insider Sale: CFO and Treasurer James Edgemond Sells 40,160 Shares of United Therapeutics Corp ... (GuruFocus.com)
May-15-24 02:05AM	Q1 2024 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
May-14-24 04:39PM	United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing (MT Newswires)
May-10-24 04:41PM	United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing (MT Newswires)
May-09-24 11:47AM	MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 05:15PM	United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing (MT Newswires)
09:50AM	Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term (Zacks)
May-07-24 05:00PM	United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing (MT Newswires)
02:23AM	Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
02:23AM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
May-06-24 04:43PM	United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing (MT Newswires)
02:30PM	3 Biotech Stocks to Double Your Money in the Next 24 Months (InvestorPlace)
12:45PM	United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
09:15AM	United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run? (Zacks)
May-05-24 08:19AM	Bright Horizons Family Solutions Inc. (NYSE:BFAM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 07:50PM	Analyst Report: United Therapeutics Corporation (Morningstar Research)
04:39PM	United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing (MT Newswires)
02:41PM	30 Most Profitable Companies with Highest Margins in the World (Insider Monkey)
May-02-24 11:59AM	United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales (Zacks)
11:43AM	United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:35AM	UBS Adjusts Price Target on United Therapeutics to $300 From $290, Maintains Buy Rating (MT Newswires)
09:54AM	Oppenheimer Adjusts United Therapeutics Price Target to $400 From $375, Maintains Outperform Rating (MT Newswires)
03:12AM	United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ... (GuruFocus.com)
01:06AM	Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight (GuruFocus.com)
12:07AM	Q1 2024 United Therapeutics Corp Earnings Call (Thomson Reuters StreetEvents)
May-01-24 04:35PM	Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity (Benzinga) +8.88%
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics (Zacks)
08:46AM	United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell (MT Newswires)
07:51AM	United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
06:35AM	United Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports First Quarter 2024 Financial Results (Business Wire)
Apr-29-24 12:00PM	What Makes United Therapeutics (UTHR) a New Buy Stock (Zacks)
Apr-26-24 02:02PM	CORRECTING and REPLACING PHOTO United Therapeutics Announces Worlds First Successful Xenothymokidney Transplant (Business Wire)
Apr-24-24 12:10PM	Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy? (Zacks)
09:00AM	United Therapeutics Announces Worlds First Successful Xenothymokidney Transplant (Business Wire)
07:00AM	United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 (Business Wire)
Apr-23-24 04:39PM	United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing (MT Newswires)
11:06AM	United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says (MT Newswires)
Apr-16-24 07:00AM	United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference (Business Wire)
Apr-10-24 01:46PM	Innovation in Healthcare: HTECs Q1 2024 Index Rebalance (ETF Trends)
Apr-06-24 01:55AM	Insider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United ... (GuruFocus.com)
Apr-05-24 01:52AM	Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ... (GuruFocus.com)
Apr-03-24 08:02PM	3 Underappreciated Healthcare Stocks to Buy Now: April 2024 (InvestorPlace)
Mar-29-24 07:00PM	United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 29,125 Shares (GuruFocus.com)
Mar-27-24 07:00PM	United Therapeutics Corp (UTHR) CEO Martine Rothblatt Sells 30,000 Shares (GuruFocus.com) -5.57%
Mar-26-24 10:00AM	United Therapeutics' Robust Portfolio Fuels Double-Digit Growth (GuruFocus.com)
07:00AM	United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation (Business Wire)
Mar-25-24 07:00PM	Insider Sell: United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells ... (GuruFocus.com)
07:00AM	United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program (Business Wire)
Mar-22-24 09:04PM	Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ... (GuruFocus.com)
11:30AM	Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report? (Zacks)
Mar-21-24 07:01PM	United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares (GuruFocus.com)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-16-24 02:42PM	Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-13-24 10:54PM	Q4 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
03:12PM	The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024 (InvestorPlace)
Mar-11-24 07:01PM	United Therapeutics Corp Chairperson & CEO Martine Rothblatt Sells 30,000 Shares (GuruFocus.com)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 03:01AM	Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ... (GuruFocus.com)
Mar-05-24 06:28AM	Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making (InvestorPlace)
06:00AM	United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024 (Business Wire)
Feb-27-24 06:00AM	United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference (Business Wire)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 24 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 24 '24	Sale	334.00	3,600	1,202,414	130	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 23 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 23 '24	Sale	335.38	3,600	1,207,368	130	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 22 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 22 '24	Sale	331.32	3,600	1,192,738	130	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 19 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 19 '24	Sale	329.59	3,600	1,186,506	130	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 18 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 18 '24	Sale	331.79	3,600	1,194,438	130	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 17 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 17 '24	Sale	333.69	3,600	1,201,298	130	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 16 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 16 '24	Sale	328.03	3,600	1,180,909	130	Jul 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 15 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 15 '24	Sale	326.29	3,600	1,174,636	130	Jul 17 04:30 PM
Giltner Richard	Director	Jul 13 '24	Option Exercise	0.00	1,800	0	17,420	Jul 15 04:30 PM
PATUSKY CHRISTOPHER	Director	Jul 13 '24	Option Exercise	0.00	900	0	900	Jul 15 04:30 PM
Olian Judy D.	Director	Jul 13 '24	Option Exercise	0.00	1,800	0	7,405	Jul 15 04:30 PM
Mesa Nilda	Director	Jul 13 '24	Option Exercise	0.00	900	0	6,007	Jul 15 04:30 PM
KURZWEIL RAY	Director	Jul 13 '24	Option Exercise	0.00	900	0	12,080	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 12 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 12 '24	Sale	324.97	3,600	1,169,875	130	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 11 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 11 '24	Sale	325.96	3,600	1,173,470	130	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 10 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 10 '24	Sale	326.35	3,600	1,174,858	130	Jul 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 09 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 09 '24	Sale	322.74	3,600	1,161,846	130	Jul 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 08 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 09 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 08 '24	Sale	317.05	3,600	1,141,378	130	Jul 09 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 05 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 09 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 05 '24	Sale	313.25	3,600	1,127,707	130	Jul 09 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 03 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 03 '24	Sale	312.48	3,600	1,124,934	130	Jul 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 02 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 02 '24	Sale	318.22	3,600	1,145,608	130	Jul 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 01 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 02 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 01 '24	Sale	320.45	3,600	1,153,614	130	Jul 02 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 28 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 02 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 28 '24	Sale	318.56	3,600	1,146,825	130	Jul 02 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 27 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 28 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 27 '24	Sale	316.62	3,600	1,139,822	130	Jun 28 04:30 PM
Thompson Tommy G	Director	Jun 26 '24	Option Exercise	175.43	7,500	1,315,725	15,980	Jun 28 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 26 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 28 04:30 PM
Thompson Tommy G	Director	Jun 26 '24	Sale	319.34	7,500	2,395,035	8,480	Jun 28 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 26 '24	Sale	318.37	3,600	1,146,119	130	Jun 28 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 25 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 25 '24	Sale	319.33	3,600	1,149,572	130	Jun 26 04:30 PM
Mesa Nilda	Director	Jun 25 '24	Sale	318.58	266	84,742	5,107	Jun 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 24 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 24 '24	Sale	315.97	3,600	1,137,500	130	Jun 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 21 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 24 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 21 '24	Sale	313.91	3,600	1,130,080	130	Jun 24 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Jun 20 '24	Option Exercise	163.30	25,000	4,082,500	61,710	Jun 24 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 20 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 24 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 20 '24	Sale	308.97	3,600	1,112,309	130	Jun 24 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 18 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 20 04:30 PM
CAUSEY CHRISTOPHER	Director	Jun 18 '24	Option Exercise	112.14	3,000	336,420	7,185	Jun 20 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 18 '24	Sale	303.64	3,600	1,093,104	130	Jun 20 04:30 PM
CAUSEY CHRISTOPHER	Director	Jun 18 '24	Sale	304.18	3,000	912,538	4,185	Jun 20 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 17 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 20 04:30 PM
PATUSKY CHRISTOPHER	Director	Jun 17 '24	Option Exercise	76.36	2,000	152,720	2,000	Jun 18 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 17 '24	Sale	293.51	3,600	1,056,624	130	Jun 20 04:30 PM
PATUSKY CHRISTOPHER	Director	Jun 17 '24	Sale	295.50	2,000	591,000	0	Jun 18 04:30 PM
Olian Judy D.	Director	Jun 17 '24	Sale	295.43	1,700	502,225	5,605	Jun 18 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 14 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 14 '24	Sale	287.22	3,600	1,033,984	130	Jun 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 13 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 14 04:30 PM
CAUSEY CHRISTOPHER	Director	Jun 13 '24	Option Exercise	112.14	2,000	224,280	6,185	Jun 14 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 13 '24	Sale	285.48	3,600	1,027,716	130	Jun 14 04:30 PM
CAUSEY CHRISTOPHER	Director	Jun 13 '24	Sale	281.53	2,000	563,055	4,185	Jun 14 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 12 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 12 '24	Sale	281.19	3,600	1,012,293	130	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 11 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 11 '24	Sale	275.71	3,600	992,558	130	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 10 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 10 '24	Sale	273.95	3,600	986,204	130	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 07 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 07 '24	Sale	277.13	3,600	997,658	130	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 06 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 06 '24	Sale	276.98	3,600	997,124	130	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 05 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 05 '24	Sale	277.50	3,600	998,995	130	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 04 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 04 '24	Sale	273.38	3,600	984,150	130	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 03 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 03 '24	Sale	276.65	3,600	995,950	130	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 31 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 31 '24	Sale	272.48	3,600	980,940	130	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 30 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 30 '24	Sale	270.10	3,600	972,350	130	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Director	May 29 '24	Option Exercise	129.49	3,600	466,164	3,730	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 29 '24	Sale	267.13	3,600	961,663	130	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 28 '24	Option Exercise	129.49	3,600	466,164	3,730	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 28 '24	Sale	269.06	3,600	968,620	130	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 24 '24	Option Exercise	129.49	3,600	466,164	3,730	May 28 04:30 PM
ROTHBLATT MARTINE A	Director	May 24 '24	Sale	272.53	3,600	981,119	130	May 28 04:30 PM
ROTHBLATT MARTINE A	Director	May 23 '24	Option Exercise	129.49	3,600	466,164	3,730	May 28 04:30 PM
ROTHBLATT MARTINE A	Director	May 23 '24	Sale	275.78	3,600	992,824	130	May 28 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

UTHR

United Therapeutics Corp

Upgrade your FINVIZ experience